Making the Call in Type 2 Diabetes: GLP-1 Receptor Agonists and Reducing Stroke Risk
This activity is jointly provided by Global Education Group and Integritas Communications.
This activity is jointly provided by Global Education Group and Integritas Communications.
Program Overview
Cardiovascular disease (CVD) is the leading cause of death among patients with type 2 diabetes (T2D). Among the potential cardiovascular complications of T2DM, stroke is a particularly high risk for patients, especially given the aging population. Increasing rates of diabetes, hypertension, and obesity are also placing a larger population of younger patients at risk for stroke. Some antidiabetic therapies, including certain glucagon-like peptide-1 (GLP-1) receptor agonists, can reduce the CVD risks in patients with T2D and contribute to secondary prevention. Expert faculty discussions in this Phone-a-Friend series will address specific challenges related to the management of patients with T2D, the risk of stroke, and the roles of GLP-1 receptor agonists.
Target Audience
The educational design of this activity addresses the needs of endocrinologists, neurologists, cardiologists, and primary care providers (PCPs), including nurse practitioners (NPs) and physician assistants (PAs), who manage patients with type 2 diabetes (T2D) at risk for stroke.
Modules
GLP-1 Receptor Agonists and Cardiovascular Risks
Faculty David Spence C.M, MD, FRCPC, FAHA & Charles P Vega, MD, FAAFP
Credits Maximum of 0.25 AMA PRA Category 1 Credit™ and 0.25 AANP contact hour(s)
Expiration2023-09-29
Educating Patients With T2D About Stroke Risk
Faculty Eileen Egan, DNP, FNP-C, BC-ADM, CDCES, FADCE & Charles P Vega, MD, FAAFP
Credits Maximum of 0.25 AMA PRA Category 1 Credit™ and 0.25 AANP contact hour(s)
Expiration2023-10-18
Managing Patients With T2D Who Are Recovering From a Stroke
Faculty David Spence C.M, MD, FRCPC, FAHA & Charles P Vega, MD, FAAFP
Credits Maximum of 0.25 AMA PRA Category 1 Credit™ and 0.25 AANP contact hour(s)
Expiration2023-11-11
The Pathophysiology of T2D and Stroke
Faculty David Spence C.M, MD, FRCPC, FAHA & Charles P Vega, MD, FAAFP
Credits Maximum of 0.25 AMA PRA Category 1 Credit™ and 0.25 AANP contact hour(s)
Expiration2023-11-30